Viewing Study NCT02395159


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2026-01-14 @ 7:52 AM
Study NCT ID: NCT02395159
Status: COMPLETED
Last Update Posted: 2017-10-27
First Post: 2015-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Reduction of Groin Wound Infections After Vascular Surgery by Using an Incision Management System (IMS)
Sponsor: RWTH Aachen University
Organization:

Study Overview

Official Title: Reduction of Groin Wound Infections After Vascular Surgery in Patients With Risk Factors by the Use a Negative Pressure Wound Incision Management System (KCI Prevena)
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IMS
Brief Summary: Comparison of the Prevena™ IMS with the standard wound management method of sterile plaster in vascular surgery patients.
Detailed Description: Comparison of the Prevena™ IMS with the standard wound management method of sterile plaster in vascular surgery patients.

The aim is to demonstrate that the application of the Prevena™ IMS significantly reduces the incidence of postoperative wound infections. The wound infections will be classified according to Szilagyi.

The treatment phase begins following vascular surgery with wound management using either the Prevena™ IMS or a standard wound dressing, depending on the group to which the patient was randomly assigned. It involves a minimum stay of 7 and maximum 10 days in hospital.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: